rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Stuart A. Tross

Chief People & Workpl Officer

Company insider

Files Form 4 as: Chief People & Workpl Officer, MannKind; SVP, Human Resources, Amgen.

Every Form 4 they filed

In numbers

Trades disclosed
125
Buys
13
Sells
7
Bought
$232K
Sold
$3.1M
Companies
2
Companies where not an officer
0
First trade
25 Oct 2013
Last trade
15 Jul 2026
Last filed
17 Jul 2026

Companies traded

Where they are an officer
MNKD MannKindOfficer · Pharmaceuticals · last 15 Jul 202613 buys · 5 sells
AMGN AmgenOfficer · Biotechnology · last 3 May 20160 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code M—93,790 at $0.00filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$138K33,652 at $4.09filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$34K8,253 at $4.09filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code M—93,790 at $0.00filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$47K11,572 at $4.09filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$50K12,331 at $4.09filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code M—93,790 at $0.00filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code M—93,790 at $0.00filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$138K33,652 at $4.09filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$34K8,253 at $4.09filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$47K11,572 at $4.09filing
15 Jul 2026filed 17 Jul 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$50K12,331 at $4.09filing
20 May 2026filed 22 May 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code A$100K33,898 at $2.95filing
20 May 2026filed 22 May 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code A$100K33,898 at $2.95filing
11 May 2026filed 13 May 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$28K8,073 at $3.52filing
11 May 2026filed 13 May 2026MNKD MannKindPharmaceuticalsSEC FORM 4 Code F$28K8,073 at $3.52filing
23 Mar 2026filed 25 Mar 2026MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—221,000 at $0.00filing
23 Mar 2026filed 25 Mar 2026MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—217,000 at $0.00filing
23 Mar 2026filed 25 Mar 2026MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—221,000 at $0.00filing
23 Mar 2026filed 25 Mar 2026MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—217,000 at $0.00filing

Sectors

Health Care20

Buys in green, sells in red, by the company’s sector.

Related people

Steven B. BinderDirector · Director at Mannkind, filing Form 4 there in the last year
Rachna KhoslaSVP, Business Development · SVP, Business Development at Amgen, filing Form 4 there in the last year
Matthew C. BuschVP, Finance & CAO · VP, Finance & CAO at Amgen, filing Form 4 there in the last year
Charles M. HolleyDirector · Director at Amgen, filing Form 4 there in the last year
Michael Drake VDirector · Director at Amgen, filing Form 4 there in the last year
David J. TaylorRepresentative, OH-02 · Also traded AMGN in the last 90 days
Sheldon WhitehouseSenator, RI · Also traded AMGN in the last 90 days
Derek MillerSVP, Human Resources · Also traded AMGN in the last 90 days